Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials
Public concern is high regarding the timely and complete reporting
of clinical trial results, primarily when the trials are sponsored
by the drug, biologicals, or device industries. Because academic
researchers and their institutions often play a prominent role in
such trials, these concerns challenge the integrity of the academic
medical research community as well as the sponsors of the trials.
The AAMC held a small invitational conference June 22-23, 2005,
to address these concerns. The conference produced a set of principles
and standards (PDF) that should guide institutions
and their investigators in the analysis and reporting of clinical
trials in which they participate.
Related Resources
This page contains documents in Portable Document Format (PDF).
The Adobe Acrobat® Reader® is required to view PDF documents. Download
Acrobat® Reader®.
|
